Aptevo Therapeutics Inc. (APVO): Nasdaq/NYSE listing notice — Aptevo receives Nasdaq delisting notice for equity deficiency; announces 1-for-20 reverse split

Aptevo Therapeutics Inc.

Nasdaq notified Aptevo of non-compliance with $2.5M stockholders' equity rule; deficit of $1.473M as of March 31, 2025.
Company has 45 days (by July 7, 2025) to submit compliance plan; if accepted, until Nov 18, 2025 to regain compliance.
Announces 1-for-20 reverse stock split effective May 23, 2025; shares begin trading split-adjusted May 27.
Files prospectus supplement for up to $3.015M of common stock under ATM with Roth Capital.
Outstanding shares to reduce from ~13.5M to ~0.7M; no change to ticker APVO.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Aptevo Therapeutics Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

May 22, 2025, Aptevo Therapeutics Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. On its Quarterly Report for the quarterly period ended March 31, 2025, the Company reported stockholders’ deficit of $1,473,000, and, as a result, does not currently satisfy Nasdaq Listing Rule 5550(b)(1). Nasdaq’s letter has no immediate impact on the listing o

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Aptevo Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-076482

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.